Manulife Financial Corp (MFC-PM.TO)

23.680.18 (-0.75%)

Manulife Financial Corp (MFC-PM.TO) stock comprehensive Financial Growth Analysis including revenue, gross profit, operating profit, net profit, EPS, and other financial metrics. Compare financial growth against peers/competitors, industry and sector standards.

High Bankruptcy RiskAttractive ValuationLow ProfitabilityAdequate Financial HealthInefficient OperationsModerate GrowthModerate QualityAdequate Dividend ProfileIndustry Rank: 82.19%Sector Rank: 83.29%

TSX - Financial Services - Insurance - Life | Market Cap: 40.56B | Next Earnings Date: 6 Aug 2025

Day's Range

23.68 - 23.68

52-Week Range

20.75 - 25.07

Volume

1.4K / 5.9K (Avg.)

Trending:

MFC-PM.TO Financial Growth Analysis

Evaluation Basis

Value Investing Sector Medians Industry Medians

Select Period

2025 (Q2)2025 (Q1)2024 (Q4)2024 (Q3)2024 (Q2)2024 (Q1)2023 (Q4)2023 (Q3)

Compare against a Competitor

None MFC-PL.TO MFC-PN.TO MFC-PF.TO MFC-PI.TO MFC-PK.TO

Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.

Revenue Growth

-4.12%

Decreased from previous period

Negative revenue growth while Insurance - Life median is 0.00%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.

Gross Profit Growth

-4.12%

Decreased from previous period

Negative gross profit growth while Insurance - Life median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.

EBIT Growth

23.96%

Increased from previous period

EBIT growth of 23.96% while Insurance - Life median is zero. Walter Schloss would see a marginal edge that could be expanded upon.

Operating Income Growth

23.96%

Increased from previous period

Operating income growth exceeding 1.5x Insurance - Life median of 1.30%. Joel Greenblatt would see if unique processes drive exceptional profitability.

Net Income Growth

20.97%

Increased from previous period

Net income growth of 20.97% while Insurance - Life median is zero. Walter Schloss might see potential if moderate gains can keep rising.

EPS Growth

20.93%

Increased from previous period

EPS growth of 20.93% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.

Diluted EPS Growth

21.02%

Increased from previous period

Diluted EPS growth of 21.02% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could improve over time.

Share Count Growth (Basic)

No Data

No Data available this quarter, please select a different quarter.

Share Count Growth (Diluted)

No Data

No Data available this quarter, please select a different quarter.

Dividend per Share Growth

No Data

No Data available this quarter, please select a different quarter.

Operating Cash Flow Growth

90.53%

Increased from previous period

OCF growth exceeding 1.5x Insurance - Life median of 10.43%. Joel Greenblatt would see if a superior business model or cost structure drives strong cash generation.

Free Cash Flow Growth

90.53%

Increased from previous period

FCF growth exceeding 1.5x Insurance - Life median of 10.43%. Joel Greenblatt would see if high profitability or prudent capex drives outperformance.

10-Year Revenue Growth per Share (CAGR)

109.66%

Decreased from previous period

10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 64.79%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.

5-Year Revenue Growth per Share (CAGR)

128.39%

Decreased from previous period

5Y revenue/share growth exceeding 1.5x Insurance - Life median of 0.27%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.

3-Year Revenue Growth per Share (CAGR)

85.62%

Decreased from previous period

3Y revenue/share growth exceeding 1.5x Insurance - Life median of 26.43%. Joel Greenblatt might see a short-term competitive advantage at play.

10-Year Operating Cash Flow Growth per Share

219.29%

OCF/share CAGR exceeding 1.5x Insurance - Life median of 45.55% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.

5-Year Operating Cash Flow Growth per Share

1368.45%

Increased from previous period

5Y OCF/share growth exceeding 1.5x Insurance - Life median of 45.94%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.

3-Year Operating Cash Flow Growth per Share

179.10%

Decreased from previous period

3Y OCF/share growth > 1.5x Insurance - Life median of 26.09%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.

10-Year Net Income Growth per Share

268.16%

Increased from previous period

Net income/share CAGR near Insurance - Life median. Charlie Munger might see typical industry-level profit expansion over 10 years.

5-Year Net Income Growth per Share

214.02%

Increased from previous period

5Y net income/share CAGR > 1.5x Insurance - Life median of 57.31%. Joel Greenblatt might see superior mid-term capital allocation or product strength.

3-Year Net Income Growth per Share

144.19%

Increased from previous period

3Y net income/share CAGR > 1.5x Insurance - Life median of 43.24%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.

10-Year Shareholders’ Equity Growth per Share

229.84%

Increased from previous period

Equity/share CAGR exceeding 1.5x Insurance - Life median of 6.07% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.

5-Year Shareholders’ Equity Growth per Share

198.13%

Decreased from previous period

5Y equity/share CAGR > 1.5x Insurance - Life median of 52.33%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.

3-Year Shareholders’ Equity Growth per Share

171.91%

Increased from previous period

3Y equity/share CAGR > 1.5x Insurance - Life median of 28.09%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.

10-Year Dividend per Share Growth (CAGR)

No Data

No Data available this quarter, please select a different quarter.

5-Year Dividend per Share Growth (CAGR)

No Data

No Data available this quarter, please select a different quarter.

3-Year Dividend per Share Growth (CAGR)

No Data

No Data available this quarter, please select a different quarter.

Receivables Growth

No Data

No Data available this quarter, please select a different quarter.

Inventory Growth

No Data

No Data available this quarter, please select a different quarter.

Asset Growth

1.46%

Increased from previous period

Asset growth of 1.46% while Insurance - Life median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.

Book Value per Share Growth

1.81%

Increased from previous period

BV/share growth exceeding 1.5x Insurance - Life median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.

Debt Growth

117.93%

Increased from previous period

Debt growth of 117.93% while Insurance - Life median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.

R&D Expense Growth

No Data

No Data available this quarter, please select a different quarter.

SG&A Expenses Growth

-12.97%

Decreased from previous period

SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.

+ Add New Metric (Coming Soon)

Add more metric or remove existing ones, customize as per your preference, feature coming soon!

Select Chart Metric:

MFC-PM.TO Financial Growth Analysis

Evaluation Basis

Value Investing Sector Medians Industry Medians

Select Period

2025 (Q2)2025 (Q1)2024 (Q4)2024 (Q3)2024 (Q2)2024 (Q1)2023 (Q4)2023 (Q3)

Compare against a Competitor

None MFC-PL.TO MFC-PN.TO MFC-PF.TO MFC-PI.TO MFC-PK.TO

Revenue Growth

-4.12%

Decreased from previous period

Negative revenue growth while Insurance - Life median is 0.00%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.

Gross Profit Growth

-4.12%

Decreased from previous period

Negative gross profit growth while Insurance - Life median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.

EBIT Growth

23.96%

Increased from previous period

EBIT growth of 23.96% while Insurance - Life median is zero. Walter Schloss would see a marginal edge that could be expanded upon.

Operating Income Growth

23.96%

Increased from previous period

Operating income growth exceeding 1.5x Insurance - Life median of 1.30%. Joel Greenblatt would see if unique processes drive exceptional profitability.

Net Income Growth

20.97%

Increased from previous period

Net income growth of 20.97% while Insurance - Life median is zero. Walter Schloss might see potential if moderate gains can keep rising.

EPS Growth

20.93%

Increased from previous period

EPS growth of 20.93% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.

Diluted EPS Growth

21.02%

Increased from previous period

Diluted EPS growth of 21.02% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could improve over time.

Share Count Growth (Basic)

No Data

No Data available this quarter, please select a different quarter.

Share Count Growth (Diluted)

No Data

No Data available this quarter, please select a different quarter.

Dividend per Share Growth

No Data

No Data available this quarter, please select a different quarter.

Operating Cash Flow Growth

90.53%

Increased from previous period

OCF growth exceeding 1.5x Insurance - Life median of 10.43%. Joel Greenblatt would see if a superior business model or cost structure drives strong cash generation.

Free Cash Flow Growth

90.53%

Increased from previous period

FCF growth exceeding 1.5x Insurance - Life median of 10.43%. Joel Greenblatt would see if high profitability or prudent capex drives outperformance.

10-Year Revenue Growth per Share (CAGR)

109.66%

Decreased from previous period

10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 64.79%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.

5-Year Revenue Growth per Share (CAGR)

128.39%

Decreased from previous period

5Y revenue/share growth exceeding 1.5x Insurance - Life median of 0.27%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.

3-Year Revenue Growth per Share (CAGR)

85.62%

Decreased from previous period

3Y revenue/share growth exceeding 1.5x Insurance - Life median of 26.43%. Joel Greenblatt might see a short-term competitive advantage at play.

10-Year Operating Cash Flow Growth per Share

219.29%

OCF/share CAGR exceeding 1.5x Insurance - Life median of 45.55% over 10 years. Joel Greenblatt would verify if a unique competitive moat underlies these cash flows.

5-Year Operating Cash Flow Growth per Share

1368.45%

Increased from previous period

5Y OCF/share growth exceeding 1.5x Insurance - Life median of 45.94%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.

3-Year Operating Cash Flow Growth per Share

179.10%

Decreased from previous period

3Y OCF/share growth > 1.5x Insurance - Life median of 26.09%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.

10-Year Net Income Growth per Share

268.16%

Increased from previous period

Net income/share CAGR near Insurance - Life median. Charlie Munger might see typical industry-level profit expansion over 10 years.

5-Year Net Income Growth per Share

214.02%

Increased from previous period

5Y net income/share CAGR > 1.5x Insurance - Life median of 57.31%. Joel Greenblatt might see superior mid-term capital allocation or product strength.

3-Year Net Income Growth per Share

144.19%

Increased from previous period

3Y net income/share CAGR > 1.5x Insurance - Life median of 43.24%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.

10-Year Shareholders’ Equity Growth per Share

229.84%

Increased from previous period

Equity/share CAGR exceeding 1.5x Insurance - Life median of 6.07% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.

5-Year Shareholders’ Equity Growth per Share

198.13%

Decreased from previous period

5Y equity/share CAGR > 1.5x Insurance - Life median of 52.33%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.

3-Year Shareholders’ Equity Growth per Share

171.91%

Increased from previous period

3Y equity/share CAGR > 1.5x Insurance - Life median of 28.09%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.

10-Year Dividend per Share Growth (CAGR)

No Data

No Data available this quarter, please select a different quarter.

5-Year Dividend per Share Growth (CAGR)

No Data

No Data available this quarter, please select a different quarter.

3-Year Dividend per Share Growth (CAGR)

No Data

No Data available this quarter, please select a different quarter.

Receivables Growth

No Data

No Data available this quarter, please select a different quarter.

Inventory Growth

No Data

No Data available this quarter, please select a different quarter.

Asset Growth

1.46%

Increased from previous period

Asset growth of 1.46% while Insurance - Life median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.

Book Value per Share Growth

1.81%

Increased from previous period

BV/share growth exceeding 1.5x Insurance - Life median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.

Debt Growth

117.93%

Increased from previous period

Debt growth of 117.93% while Insurance - Life median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.

R&D Expense Growth

No Data

No Data available this quarter, please select a different quarter.

SG&A Expenses Growth

-12.97%

Decreased from previous period

SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.

+ Add New Metric (Coming Soon)

Add more metric or remove existing ones, customize as per your preference, feature coming soon!

Select Chart Metric: